{"id":"conventional-fecal-microbiota-transplantation","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal symptoms (abdominal pain, bloating, diarrhea)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Infection transmission (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT works by transferring stool from a healthy donor into the gastrointestinal tract of a patient with dysbiosis, reestablishing beneficial microbial populations and their metabolic functions. This restores microbial diversity and competitive exclusion of pathogenic organisms, particularly Clostridioides difficile. The reconstituted microbiota produces short-chain fatty acids and other metabolites that support intestinal barrier function and immune homeostasis.","oneSentence":"Fecal microbiota transplantation restores a healthy gut microbiome by introducing diverse bacterial communities from a donor to treat dysbiosis-related conditions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:45:23.004Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (recurrent or refractory)"},{"name":"Inflammatory bowel disease (Crohn's disease, ulcerative colitis)"}]},"trialDetails":[{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT07003438","phase":"EARLY_PHASE1","title":"Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children","status":"NOT_YET_RECRUITING","sponsor":"Zhang Ting","startDate":"2025-06-01","conditions":"Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome","enrollment":120},{"nctId":"NCT06641778","phase":"NA","title":"Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia","status":"RECRUITING","sponsor":"luxia Kong","startDate":"2024-12-03","conditions":"Klebsiella Pneumoniae Pneumonia","enrollment":100},{"nctId":"NCT06368895","phase":"PHASE1","title":"Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-04-07","conditions":"Hepatic Encephalopathy, Dysbiosis","enrollment":60},{"nctId":"NCT05654753","phase":"PHASE2, PHASE3","title":"The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-03-28","conditions":"Axial Spondyloarthritis","enrollment":20},{"nctId":"NCT04960306","phase":"PHASE3","title":"Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection","status":"UNKNOWN","sponsor":"University of Pecs","startDate":"2023-11-01","conditions":"Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection","enrollment":238},{"nctId":"NCT05229289","phase":"NA","title":"Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-31","conditions":"Hepatic Encephalopathy","enrollment":66},{"nctId":"NCT02318147","phase":"PHASE1","title":"Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2016-11","conditions":"Acute Pancreatitis, Fecal Microbiota Transplantation, Bacterial Translocation","enrollment":60},{"nctId":"NCT02526849","phase":"PHASE2","title":"Efficacy and Safety of Fecal Microbiota Transplantation for Slow Transit Constipation","status":"UNKNOWN","sponsor":"Jinling Hospital, China","startDate":"2015-11","conditions":"Slow Transit Constipation","enrollment":100},{"nctId":"NCT02461199","phase":"","title":"Stool Transplantation to Reduce Antibiotic Resistance Transmission","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2015-02","conditions":"Blood Disorders","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":194,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Conventional fecal microbiota transplantation","genericName":"Conventional fecal microbiota transplantation","companyName":"University of Pecs","companyId":"university-of-pecs","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fecal microbiota transplantation restores a healthy gut microbiome by introducing diverse bacterial communities from a donor to treat dysbiosis-related conditions. Used for Clostridioides difficile infection (recurrent or refractory), Inflammatory bowel disease (Crohn's disease, ulcerative colitis).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}